VICTORIA LABATUT: Open Payments
NPI 1992376834 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 41 payments from 18 companies in 2025. Trend: 2023 $791 · 2024 $1,079 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $180 |
| Fresenius USA Marketing, Inc. | 4 | $101 |
| Calliditas Therapeutics US Inc. | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| NxStage Medical, Inc. | 1 | $76 |
| Novo Nordisk Inc | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Mallinckrodt Hospital Products Inc. | 3 | $55 |
| AKEBIA THERAPEUTICS INC | 1 | $38 |
| GENZYME CORPORATION | 2 | $36 |
Products named: Fabhalta, VELPHORO, TARPEYO, Kerendia, NXSTAGE SYSTEM ONE, Vanrafia, JYNARQUE, ACTHAR.
Industry payments across LA — which companies pay providers there.
